New drug combo shows promise for hard-to-treat lymphoma
NCT ID NCT05852717
First seen Jan 12, 2026 · Last updated May 01, 2026 · Updated 19 times
Summary
This study tests a new combination of the drug epcoritamab plus chemotherapy (GDP) in 32 adults with relapsed or refractory large B-cell lymphoma. The goal is to see if this combo can shrink tumors enough to allow patients to proceed to a stem cell transplant or CAR T-cell therapy. Participants receive 3 cycles of the combo, then may continue epcoritamab alone if they respond but cannot have transplant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
RECRUITINGIndianapolis, Indiana, 46202, United States
Contact Email: •••••@•••••
Contact
-
Karmanos Cancer Center (Wayne State University)
RECRUITINGDetroit, Michigan, 48201, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Texas Southwestern Medical Center
RECRUITINGDallas, Texas, 75390, United States
Contact
Contact Email: •••••@•••••
-
University of Virginia Health System
RECRUITINGCharlottesville, Virginia, 22908, United States
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.